相关实验视频

Updated: Jun 19, 2025

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

16.9K

KM04416通过促进免疫透抑制了肺腺癌的进展

Yalan Lin1, Weijing Wu1, Huihuang Lin1

  • 1Department of Pulmonary and Critical Care Medicine, Respiratory Medicine Center of Fujian Province, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.

Journal of cardiothoracic surgery
|July 25, 2024
PubMed
概括

用KM04416准甘-3-酸盐脱酶2 (GPD2) 抑制了肺腺癌 (LUAD) 的进展. 这种GPD2抑制影响免疫细胞透,为LUAD提供了潜在的新治疗策略.

关键词:
免疫系统的透.在KM0441616的基础上.肺部腺癌瘤是肺部腺癌.一个进步的进步.

更多相关视频

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.2K
Lung Tumor Cell Recruitment Assay04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

5.3K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501